Shimadzu's new TOC-L Series combines the proven combustion catalytic oxidation at 680 °C and NDIR detection method with user friendly design.
This product conforms to Shimadzu’s eco-labeled designation. Energy consumption has been reduced by 43 % (200 V) in comparison with conventional Shimadzu models.
Shimadzu’s new TOC-L Series combines the proven combustion catalytic oxidation at 680 °C and NDIR detection method with user friendly design. The heart of the TOC-L instrument is the ISP (integrated sample pretreatment system), consisting of an 8-port valve and a syringe with sparging gas connection. The ISP module allows automatic dilution which is extremely useful for various applications. The measuring range for TOC determination is increased up to 30,000 mg/L. Samples contaminated with high salt can be diluted automatically. Where the TOC concentration does not allow a dilution, the new high salt kit can handle these samples. This increases the lifetime of the catalyst and combustion tube while reducing maintenance time and running costs of the TOC analyzer. For simultaneous TOC and Total Nitrogen analysis, the TNM-L system can be added without increasing the size of the footprint. Highly sensitive chemiluminescence detection offers a measuring range between 5 µg/L and 10,000 mg/L.
TOC-Control L Software, the state-of-the-art software for PC control, combines new features with easy-to-use operation. The clear layout of the sample window editor offers users “at-a-glance” access to all relevant information. Proven functions such as control cards, validation table and export functions are included.
For further details please visit www.shimadzu.eu
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.